investig
inhibit
featur
natur
product
juglon
three
key
enzym
helicobact
pylori
cystathionin
hpcg
malonylcoa
acyl
carrier
protein
transacylas
hpfabd
dehydratas
hpfabz
method
enzym
inhibit
assay
hpcg
carri
use
continu
coupl
spectrophotometr
assay
approach
inhibit
assay
hpfabd
perform
base
dehydrogenasecoupl
system
inhibit
assay
hpfabz
monitor
detect
decreas
absorb
nm
crotonoylcoa
convers
juglonefabz
complex
crystal
obtain
soak
juglon
hpfabz
crystal
xray
crystal
structur
complex
analyz
molecular
replac
approach
result
juglon
shown
potent
inhibit
hpcg
hpfabd
hpfabz
half
maxim
inhibitori
concentr
ic
valu
respect
inhibitiontyp
studi
indic
juglon
noncompetit
inhibitor
hpcg
osuccinyllhomoserin
k
uncompetit
inhibitor
hpfabd
malonylcoa
competit
inhibitor
hpfabz
crotonoylcoa
k
moreov
crystal
structur
hpfabzjuglon
complex
reveal
essenti
bind
pattern
juglon
hpfabz
atom
level
conclus
hpcg
hpfabd
hpfabz
potenti
target
juglon
abbrevi
ic
half
maxim
inhibitori
concentr
k
dissoci
constant
inhibitor
bind
coa
coenzym
acp
acyl
carrier
protein
transacylas
pdb
protein
data
bank
hohxodh
dehydrogenas
helicobact
pylori
h
pylori
gramneg
bacterium
associ
number
human
diseas
includ
gastriti
peptic
ulcer
gastric
cancer
h
pylori
recogn
pathogen
bacterium
chronic
infect
approxim
world
human
popul
rapid
infect
h
pylori
becom
sever
threat
human
health
usual
treatment
h
pylori
infect
involv
administr
combin
antibiot
drug
howev
overus
misus
antibacteri
agent
result
gener
antibiot
resist
strain
exampl
uk
metronidazol
resist
found
h
pylori
isol
accordingli
alarm
rise
antibiot
resist
among
key
bacteri
pathogen
strongli
stimul
urgenc
develop
novel
antibacteri
agent
act
new
drug
target
natur
product
juglon
figur
leav
unrip
hull
fruit
juglacea
found
demonstr
cytotox
ad
cell
cultur
effect
might
result
juglon
involv
block
transcript
k
channel
cell
membran
inhibit
peptidylprolyl
isomeras
gener
hydrogen
peroxid
addit
juglon
found
possess
antibacteri
properti
includ
antih
pylori
antifung
properti
howev
target
inform
ever
disclos
present
studi
report
juglon
function
multitarget
inhibitor
key
enzym
h
pylori
cystathionin
hpcg
malonylcoa
acyl
carrier
protein
transacylas
hpfabd
dehydratas
hpfabz
analyz
crystal
structur
hpfabzjuglon
complex
clarifi
essenti
bind
featur
juglon
hpfabz
atom
level
known
differ
organ
display
distinct
spectra
transsulfur
enzym
plant
microb
employ
forward
pathway
cystein
homocystein
methionin
mammal
carri
revers
transsulfur
fungi
take
transsulfur
direct
cg
encod
metb
gene
pyridox
phosphatedepend
enzym
respons
reaction
activ
form
lhomoserin
lcystein
lead
lcystathionin
microorgan
reaction
first
step
involv
transsulfur
pathway
convert
lcystein
lhomocystein
sinc
cg
absent
nonrumin
anim
requir
dietari
sourc
lhomocystein
lmethionin
thu
regard
attract
target
antibiot
discoveri
howev
metb
gene
seem
unessenti
h
pylori
growth
report
salama
et
al
fatti
acid
biosynthesi
fa
essenti
pathway
surviv
organ
sinc
fatti
acid
major
compon
cell
membran
possess
import
biolog
function
natur
accord
enzym
involv
pathway
fatti
acid
biosynthesi
divid
type
type
fa
type
ii
fa
ii
fa
system
found
anim
biosynthesi
fatti
acid
catalyz
multienzym
singl
polypeptid
distinct
domain
howev
fa
ii
system
reaction
carri
seri
structur
dissoci
enzym
discov
bacteria
due
larg
differ
fa
system
enzym
like
fabd
fabz
involv
type
ii
fatti
acid
biosynthesi
develop
potenti
target
discoveri
antibacteri
agent
fabd
catalyz
transfer
malonyl
moieti
malonylcoa
holoacp
form
malonylacp
elong
substrat
fatti
acid
biosynthesi
fabz
primari
dehydratas
particip
elong
cycl
satur
unsatur
fatti
acid
synthesi
expect
current
work
might
help
understand
possibl
antibacteri
mechan
juglon
provid
use
structur
inform
discoveri
antih
pylori
agent
use
juglon
potenti
multitarget
lead
compound
materi
h
pylori
strain
maintain
institut
escherichia
coli
host
strain
purchas
stratagen
germani
natur
product
juglon
inhous
chemic
librari
establish
laboratori
chemic
use
reagent
grade
ultrapur
qualiti
hpcg
enzym
clone
express
purifi
accord
recent
publish
work
briefli
hpmetb
pcramplifi
h
pylori
strain
genom
dna
ligat
express
vector
novagen
germani
transform
restrict
digest
correct
clone
express
purifi
hpcg
enzym
obtain
use
buffer
c
mmoll
trishcl
ph
mmoll
nacl
mmoll
imidazol
elut
buffer
clone
express
purif
hpfabd
perform
accord
publish
descript
purifi
hpfabd
protein
dialyz
buffer
mmoll
trishcl
ph
remov
imidazol
clone
express
purif
hpfabz
base
recent
publish
work
purifi
protein
obtain
dialysi
buffer
b
mmoll
trishcl
ph
mmoll
nacl
mmoll
edta
hpcg
enzym
inhibit
assay
carri
accord
recent
publish
studi
ic
valu
juglon
hpcg
obtain
fit
data
sigmoid
doserespons
equat
use
origin
softwar
originlab
northampton
massachusett
usa
inhibitor
type
inhibit
constant
k
k
determin
doublereciproc
lineweaverburk
plot
v
max
plot
slope
line
doublereciproc
plot
use
function
inhibitor
concentr
hpfabd
inhibit
assay
hpfabd
enzym
inhibit
assay
perform
base
report
approach
determin
ic
valu
juglon
malonylcoa
hpfabd
incub
min
room
temperatur
differ
concentr
juglon
total
volum
investig
inhibit
mode
juglon
malonylcoa
differ
concentr
juglon
use
reaction
initi
addit
malonylcoa
ki
valu
obtain
dixon
plot
hpfabz
inhibit
assay
enzymat
inhibit
assay
hpfabz
enzym
monitor
use
report
spectrophotometr
method
ic
valu
inhibitor
estim
fit
inhibit
data
dosedepend
curv
use
logist
deriv
equat
inhibitor
mechan
determin
presenc
variou
inhibitor
concentr
h
incub
reaction
start
addit
crotonoylcoa
k
valu
obtain
dixon
plot
secondari
plot
crystal
data
collect
crystal
hpfabzjuglon
complex
carri
accord
previou
work
purifi
hpfabz
enzym
mmoll
trishcl
ph
mmoll
nacl
concentr
crystal
enzym
mix
equal
volum
reservoir
solut
contain
moll
sodium
format
moll
sodium
acet
trihydr
ph
benzamidinehcl
ad
final
concentr
wv
mixtur
equilibr
reservoir
solut
hangingdrop
vapordiffus
method
crystal
dimens
mm
obtain
juglon
ad
origin
drop
final
concentr
mmoll
crystal
soak
h
diffract
data
collect
use
xray
rigaku
raxi
iv
imag
plate
rigaku
corp
tokyo
japan
crystal
flashfrozen
liquid
nitrogen
drop
dehydr
reservoir
solut
contain
moll
sodium
format
h
data
process
use
crystallograph
statist
summar
tabl
structur
solv
molecular
replac
approach
use
crystal
structur
hpfabz
search
model
refin
program
cn
electron
densiti
interpret
model
build
perform
use
comput
graphic
program
coot
juglon
multitarget
inhibitor
cg
fabd
fabz
enzym
inhibit
cg
enzym
evalu
enzymat
assay
natur
product
juglon
identifi
show
strong
inhibitori
activ
hpcg
ic
tabl
separ
control
experi
directli
use
mmoll
substrat
juglon
show
inhibit
activ
dehydrogenas
hohxodh
concentr
even
confirm
juglon
hpcg
inhibitor
lineweaverburk
plotbas
analysi
indic
juglon
figur
inhibit
constant
k
k
tabl
determin
dixon
plot
secondari
plot
tabl
juglon
could
inhibit
hpfabd
ic
malonylcoa
noncompetit
inhibitor
figur
valu
tabl
therebi
obtain
dixon
plot
figur
besid
target
cg
fabd
juglon
also
detect
competit
inhibitor
hpfabz
ic
tabl
respect
substrat
crotonoylth
appar
valu
k
differ
inhibitor
concentr
function
inhibitor
concentr
crystal
structur
analysi
hpfabzjuglon
complex
order
gain
essenti
inhibit
mechan
atom
level
juglon
enzym
tri
crystal
enzym
complex
juglon
succeed
obtain
crystal
hpfabzjuglon
complex
well
determin
level
data
pdb
code
figur
tabl
shown
analyz
complex
structur
juglon
bind
hpfabz
bind
model
similar
previou
bind
model
hpfabz
bind
inhibitor
figur
model
juglon
fit
groov
around
entranc
figur
locat
phenol
ring
pyrrolidin
ring
form
sandwich
structur
prime
indic
residu
subunit
dimer
shown
figur
carbonyl
oxygen
juglon
form
hbond
nearbi
water
chain
also
form
hbond
back
bone
carbonyl
oxygen
atom
val
well
back
bone
nitrogen
model
b
juglon
enter
middl
tunnel
near
activ
site
hpfabz
figur
stabil
via
hydrophob
interact
residu
val
stage
carbonyl
oxygen
juglon
figur
recent
rapid
infect
h
pylori
becom
sever
threat
human
health
discoveri
new
effect
drug
attract
attent
mani
antibacteri
agent
use
standard
pathogen
clinic
subject
highlevel
resist
result
singlestep
mutat
target
enzym
wherea
multitarget
agent
might
display
low
potenti
rapid
endogen
resist
develop
pathogen
bacteria
report
juglon
could
strongli
inhibit
h
pylori
growth
low
mic
although
act
target
inform
ever
disclos
current
work
discov
juglon
function
multitarget
inhibitor
key
enzym
hpcg
hpfabd
hpfabz
provid
clue
inhibitori
mechan
underli
juglon
antih
pylori
activ
last
year
mani
cg
fabz
inhibitor
discov
howev
inhibitor
singletarget
except
flavonoid
deriv
luteolin
catechin
gallat
report
inhibit
plasmodium
falciparum
act
multitarget
inhibitor
fabg
fabz
fabi
plasmodium
falciparum
previou
work
report
natur
product
demonstr
inhibitori
activ
hpcg
consid
structur
similar
compound
juglon
contain
common
quinon
group
figur
although
natur
product
exhibit
inhibit
activ
hpfabd
hpfabz
evalu
inhibit
assay
quinon
group
seem
link
cg
enzym
inhibit
natur
product
corytuberin
first
publish
hpfabd
inhibitor
similar
corytuberin
juglon
function
uncompetit
mode
inhibit
hpfabd
tabl
addit
inhibit
studi
indic
juglon
competit
inhibitor
hpfabz
suggest
juglon
may
interfer
bind
substrat
crotonoylcoa
could
prove
inhibitor
bind
manner
complex
structur
bind
affin
juglon
hpfabz
k
higher
hpcg
hpfabd
might
attribut
competit
inhibit
type
juglon
hpfabz
previous
report
crystal
structur
hpfabz
complex
small
molecular
inhibitor
bind
model
inhibitor
hpfabz
suppos
could
form
hbond
nearbi
water
chain
also
form
hbond
back
bone
carbonyl
oxygen
bind
model
inhibitor
sandwich
phenol
ring
pyrrolidin
ring
form
interact
bind
model
b
inhibitor
locat
middl
tunnel
via
hydrophob
interact
juglon
also
fit
model
figur
posit
model
correspond
groov
around
entranc
posit
model
b
correspond
activ
site
tunnel
near
catalyt
residu
agreement
competit
inhibitori
properti
juglon
hpfabz
determin
inhibit
type
studi
howev
comparison
previou
hpfabzinhibitor
crystal
structur
analysi
major
differ
found
juglon
bind
hpfabz
first
bind
model
hpfabzjuglon
besid
hydrophob
interact
juglon
also
stabil
hbond
form
water
chain
enzym
juglon
major
differ
bind
model
b
juglon
insert
deeper
tunnel
near
suitabl
hydrophob
environ
bind
differ
previous
report
hpfabzinhibitor
bind
case
inhibitor
form
sandwichlik
conform
hpfabz
thu
espect
inform
base
hpfabzjuglon
complex
would
use
structureguid
drug
design
might
provid
novel
compet
hpfabz
inhibitor
summari
present
studi
discov
natur
product
juglon
multitarget
inhibitor
key
enzym
cg
fabd
fabz
h
pylori
obtain
crystal
structur
data
hpfabzjuglon
complex
clarifi
essenti
bind
featur
juglon
hpfabz
atom
level
although
experi
cell
label
assay
need
determin
whether
enzym
target
respons
juglon
antih
pylori
activ
juglon
could
hope
serv
potent
lead
compound
inhibitori
develop
state
multitarget
inhibitor
might
provid
low
potenti
rapid
endogen
resist
develop
prof
xu
shen
prof
hualiang
jiang
prof
lihong
hu
design
research
yunhua
kong
perform
research
analyz
data
wrote
paper
liang
zhang
determin
complex
structur
zhenyi
yang
synthes
compound
cong
han
contribut
platform
determin
mic
valu
hp
